SHEPHERD KAPLAN KROCHUK, LLC - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 212 filers reported holding NPS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
SHEPHERD KAPLAN KROCHUK, LLC ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$1,045,000
+37.5%
29,2180.0%0.17%
+73.2%
Q3 2014$760,000
-11.2%
29,218
+12.9%
0.10%
+6.6%
Q2 2014$856,000
+10.5%
25,8880.0%0.09%
+2.2%
Q1 2014$775,000
-33.1%
25,888
-32.1%
0.09%
-39.5%
Q4 2013$1,158,000
+8.2%
38,131
+13.4%
0.15%
-15.0%
Q3 2013$1,070,000
+110.6%
33,6400.0%0.17%
+73.0%
Q2 2013$508,00033,6400.10%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 424,175$12,695,0005.06%
Opaleye Management Inc. 150,000$4,490,0003.32%
OAK RIDGE INVESTMENTS LLC 2,795,331$83,664,0002.10%
SCHOLTZ & COMPANY, LLC 60,350$1,806,0001.94%
SECTORAL ASSET MANAGEMENT INC 1,408,729$42,163,0001.73%
First Light Asset Management, LLC 79,099$2,367,0001.68%
FCG ADVISORS, LLC 71,146$2,129,0001.51%
Rhenman & Partners Asset Management AB 166,970$4,997,0001.50%
BENDER ROBERT & ASSOCIATES 73,611$2,203,0001.48%
Eventide Asset Management 283,900$8,497,0001.32%
View complete list of NPS PHARMACEUTICALS INC shareholders